Skip to main content

Table 2 Univariate analysis results of factors affecting survival

From: Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients

  

5-y

OS

(%)

p value

5-y LRFFS

(%)

p value

5-y DMFS

(%)

p value

Age

≤60

68.1

.142

79.5

.998

72.8

.387

> 60

74.0

 

75.5

 

84.6

 

Orbital invasion

Yes

60.6

.008

72.8

.025

63.3

.004

No

78.9

 

85.8

 

85.1

 

Intracranial invasion

Yes

58.2

.019

71.1

.112

75.1

.785

No

75.8

 

83.6

 

73.2

 

LN

Positive

51.5

.003

74.1

.116

47.8

< 0.001

Negative

75.2

 

80.8

 

82.4

 

Kadish stage

C

65.9

.029

75.6

.134

71.2

.193

A/B

84.2

 

87.4

 

84.6

 

Concurrent chemotherapy

Yes

83.2

.027

89.5

.252

80.6

.158

No

62.4

 

73.3

 

70.1

 

Radiotherapy

2D

70.1

.748

77.1

.461

69.1

.425

3D/IMRT

74.0

 

84.7

 

75.2

 

Surgery margin

Positive

69.7

.179

79.4

.286

83.6

.451

Negative

84.9

 

88.8

 

89.3

 

Treatment

S + CCRT

90.1

< 0.001

96.7

< 0.001

93.8

< 0.001

S + RT

77.6

 

84.7

 

79.4

 

CCRT

69.7

 

75.6

 

55.5

 

RT alone

47.4

 

68.2

 

49.9

 

S alone

19.0

 

14.3

 

 
  1. LN lymph node S surgery, CCRT Concurrent chemoradiotherapy, RT radiotherapy